eicosapentaenoic acid ethyl ester has been researched along with Pregnancy in 17 studies
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An optimal fatty acid (FA) profile during pregnancy, especially docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), is essential for the health of the mother and child." | 5.41 | Maternal Factors Associated with Levels of Fatty Acids, Specifically n-3 PUFA during Pregnancy: ECLIPSES Study. ( Aparicio, E; Arija, V; Basora, J; Bedmar, C; Martín-Grau, C; Serrat Orus, NS, 2021) |
| " Supplementation with eicosapentaenoic acid (EPA)-rich oil can effectively reduce depression during pregnancy and PPD after childbirth." | 4.98 | Omega-3 polyunsaturated fatty acid supplementation in prevention and treatment of maternal depression: Putative mechanism and recommendation. ( Chen, HE; Hsu, MC; Tung, CY, 2018) |
| " The objectives of the present study were to evaluate the effect of increasing doses of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in the diet of ewes in the last third of gestation on their body weight (BW), subcutaneous adipose tissue relative mRNA abundance of genes associated with adipose tissue metabolism, and growth performance and plasma metabolites and hormones of their offspring during the finishing phase." | 3.91 | Supplementation with eicosapentaenoic and docosahexaenoic acids in late gestation in ewes changes adipose tissue gene expression in the ewe and growth and plasma concentration of ghrelin in the offspring1. ( Coleman, DN; Hamer, L; Nickles, KR; Relling, AE, 2019) |
| " Plasma eicosapentaenoic acid plus docosahexaenoic acid (EPA+DHA% of total fatty acids), were measured twice in pregnancy, at gestation weeks 9 and 25 (medians)." | 3.88 | Plasma Concentrations of Long Chain N-3 Fatty Acids in Early and Mid-Pregnancy and Risk of Early Preterm Birth. ( Cohen, AS; Furtado, JD; Giovannucci, EL; Granstrøm, C; Gørtz, S; Halldorsson, TI; Langhoff-Roos, J; Lykke, JA; Nielsen, PH; Olsen, SF; Strøm, M; Thorne-Lyman, AL; Wohlfahrt, J; Zhou, W, 2018) |
| " Supplementation with omega-3 fatty acids such as DHA and eicosapentaenoic acid (EPA) has also been associated with lipid peroxidation, which in turn has been implicated in reduced body weight and altered bone formation." | 3.88 | Maternal omega-3 polyunsaturated fatty acid supplementation on offspring hip joint conformation. ( Daniels, R; Famula, TR; Kelley, R; Levy, K; Mundell, P; Oberbauer, AM, 2018) |
| "We sought to determine whether the pressor response to an infusion of angiotensin II during pregnancy would be reduced by the oral administration of highly purified eicosapentaenoic acid ethyl ester (EPA-E)." | 3.69 | Effects of highly purified eicosapentaenoic acid on vascular reactivity to angiotensin II and norepinephrine in pregnant rabbits. ( Ito, M; Matsui, K; Okamura, H; Yoshimura, T, 1997) |
| "Depression was defined as an EPDS score ≥11." | 1.46 | Serum n-3 polyunsaturated fatty acids are inversely associated with longitudinal changes in depressive symptoms during pregnancy. ( Cunha, GM; Factor-Litvak, P; Farias, DR; Kac, G; Lepsch, J; Pinto, TJ; Vaz, JS; Vilela, AA, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 4 (23.53) | 2.80 |
| Authors | Studies |
|---|---|
| Roque-Jimenez, JA | 1 |
| Oviedo-Ojeda, MF | 1 |
| Whalin, M | 1 |
| Lee-Rangel, HA | 1 |
| Relling, AE | 3 |
| Aparicio, E | 1 |
| Martín-Grau, C | 1 |
| Bedmar, C | 1 |
| Serrat Orus, NS | 1 |
| Basora, J | 1 |
| Arija, V | 1 |
| Pearson, GJ | 1 |
| Thanassoulis, G | 1 |
| Anderson, TJ | 1 |
| Barry, AR | 1 |
| Couture, P | 1 |
| Dayan, N | 1 |
| Francis, GA | 1 |
| Genest, J | 1 |
| Grégoire, J | 1 |
| Grover, SA | 1 |
| Gupta, M | 1 |
| Hegele, RA | 1 |
| Lau, D | 1 |
| Leiter, LA | 1 |
| Leung, AA | 1 |
| Lonn, E | 1 |
| Mancini, GBJ | 1 |
| Manjoo, P | 1 |
| McPherson, R | 1 |
| Ngui, D | 1 |
| Piché, ME | 1 |
| Poirier, P | 1 |
| Sievenpiper, J | 1 |
| Stone, J | 1 |
| Ward, R | 1 |
| Wray, W | 1 |
| Woodard, V | 1 |
| Thoene, M | 1 |
| Van Ormer, M | 1 |
| Thompson, M | 1 |
| Hanson, C | 1 |
| Natarajan, SK | 1 |
| Mukherjee, M | 1 |
| Yuil-Valdes, A | 1 |
| Nordgren, TM | 1 |
| Ulu, A | 1 |
| Harris Jackson, K | 1 |
| Anderson-Berry, A | 1 |
| Alashmali, SM | 1 |
| Kitson, AP | 1 |
| Lin, L | 1 |
| Lacombe, RJS | 1 |
| Bazinet, RP | 1 |
| Hsu, MC | 1 |
| Tung, CY | 1 |
| Chen, HE | 1 |
| Olsen, SF | 1 |
| Halldorsson, TI | 1 |
| Thorne-Lyman, AL | 1 |
| Strøm, M | 1 |
| Gørtz, S | 1 |
| Granstrøm, C | 1 |
| Nielsen, PH | 1 |
| Wohlfahrt, J | 1 |
| Lykke, JA | 1 |
| Langhoff-Roos, J | 1 |
| Cohen, AS | 1 |
| Furtado, JD | 1 |
| Giovannucci, EL | 1 |
| Zhou, W | 1 |
| Oberbauer, AM | 1 |
| Daniels, R | 1 |
| Levy, K | 1 |
| Famula, TR | 1 |
| Mundell, P | 1 |
| Kelley, R | 1 |
| Nguyen, QV | 1 |
| Van Le, H | 1 |
| Nguyen, DV | 1 |
| Malau-Aduli, BS | 1 |
| Nichols, PD | 1 |
| Malau-Aduli, AEO | 1 |
| Hohos, NM | 1 |
| Cho, KJ | 1 |
| Swindle, DC | 1 |
| Allshouse, AA | 1 |
| Rudolph, MC | 1 |
| Skaznik-Wikiel, ME | 1 |
| Peng, J | 2 |
| Zhou, Y | 1 |
| Hong, Z | 1 |
| Wu, Y | 1 |
| Cai, A | 1 |
| Xia, M | 1 |
| Deng, Z | 1 |
| Yang, Y | 1 |
| Song, T | 1 |
| Xiong, J | 1 |
| Wei, H | 1 |
| Ciesielski, TH | 1 |
| Bartlett, J | 1 |
| Williams, SM | 1 |
| Coleman, DN | 2 |
| Carranza Martin, AC | 1 |
| Jin, Y | 1 |
| Lee, K | 1 |
| Nickles, KR | 1 |
| Hamer, L | 1 |
| Pinto, TJ | 1 |
| Vilela, AA | 1 |
| Farias, DR | 1 |
| Lepsch, J | 1 |
| Cunha, GM | 1 |
| Vaz, JS | 1 |
| Factor-Litvak, P | 1 |
| Kac, G | 1 |
| Chiu, CC | 1 |
| Huang, SY | 1 |
| Shen, WW | 1 |
| Su, KP | 1 |
| Yoshimura, T | 1 |
| Ito, M | 1 |
| Matsui, K | 1 |
| Okamura, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Face and Content Validation of a Healthcare Professional-facing Toolkit to Communicate Information on the Portfolio Diet and PortfolioDiet.App[NCT05915455] | 30 participants (Anticipated) | Interventional | 2023-07-10 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for eicosapentaenoic acid ethyl ester and Pregnancy
| Article | Year |
|---|---|
Omega-3 polyunsaturated fatty acid supplementation in prevention and treatment of maternal depression: Putative mechanism and recommendation.
Topics: Adult; Clinical Trials as Topic; Depression; Depression, Postpartum; Dietary Supplements; Docosahexa | 2018 |
1 trial available for eicosapentaenoic acid ethyl ester and Pregnancy
| Article | Year |
|---|---|
Maternal Factors Associated with Levels of Fatty Acids, Specifically n-3 PUFA during Pregnancy: ECLIPSES Study.
Topics: Adult; Age Factors; Docosahexaenoic Acids; Educational Status; Eicosapentaenoic Acid; Fatty Acids, O | 2021 |
15 other studies available for eicosapentaenoic acid ethyl ester and Pregnancy
| Article | Year |
|---|---|
Eicosapentaenoic and docosahexaenoic acid supplementation during early gestation modified relative abundance on placenta and fetal liver tissue mRNA and concentration pattern of fatty acids in fetal liver and fetal central nervous system of sheep.
Topics: Animals; Central Nervous System; Dietary Supplements; DNA (Cytosine-5-)-Methyltransferases; Docosahe | 2020 |
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults.
Topics: Adult; Apolipoproteins B; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Dietary Suppl | 2021 |
Intrauterine Transfer of Polyunsaturated Fatty Acids in Mother-Infant Dyads as Analyzed at Time of Delivery.
Topics: Arachidonic Acid; Cross-Sectional Studies; Eicosapentaenoic Acid; Fatty Acids; Fatty Acids, Omega-3; | 2021 |
Maternal dietary n-6 polyunsaturated fatty acid deprivation does not exacerbate post-weaning reductions in arachidonic acid and its mediators in the mouse hippocampus.
Topics: Animals; Arachidonic Acid; Eicosapentaenoic Acid; Fatty Acids, Omega-6; Female; Hippocampus; Male; M | 2019 |
Plasma Concentrations of Long Chain N-3 Fatty Acids in Early and Mid-Pregnancy and Risk of Early Preterm Birth.
Topics: Adolescent; Adult; Case-Control Studies; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, | 2018 |
Maternal omega-3 polyunsaturated fatty acid supplementation on offspring hip joint conformation.
Topics: Animals; Body Weight; Diet; Dietary Supplements; Docosahexaenoic Acids; Dogs; Eicosapentaenoic Acid; | 2018 |
Enhancement of dairy sheep cheese eating quality with increased n-3 long-chain polyunsaturated fatty acids.
Topics: alpha-Linolenic Acid; Animal Feed; Animals; Breeding; Cheese; Dairying; Diet; Docosahexaenoic Acids; | 2019 |
Fat-1 Transgene Is Associated With Improved Reproductive Outcomes.
Topics: Animals; Arachidonic Acid; Diet, High-Fat; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids | 2018 |
Maternal eicosapentaenoic acid feeding promotes placental angiogenesis through a Sirtuin-1 independent inflammatory pathway.
Topics: Angiogenesis Inducing Agents; Animals; Diet, High-Fat; Dietary Supplements; Eicosapentaenoic Acid; F | 2019 |
Omega-3 polyunsaturated fatty acid intake norms and preterm birth rate: a cross-sectional analysis of 184 countries.
Topics: Adult; alpha-Linolenic Acid; Cross-Sectional Studies; Docosahexaenoic Acids; Eicosapentaenoic Acid; | 2019 |
Prepartum fatty acid supplementation in sheep. IV. Effect of calcium salts with eicosapentaenoic acid and docosahexaenoic acid in the maternal and finishing diet on lamb liver and adipose tissue during the lamb finishing period1.
Topics: Adipose Tissue; Animal Feed; Animals; Calcium; Diet; Dietary Supplements; Docosahexaenoic Acids; Eic | 2019 |
Supplementation with eicosapentaenoic and docosahexaenoic acids in late gestation in ewes changes adipose tissue gene expression in the ewe and growth and plasma concentration of ghrelin in the offspring1.
Topics: Adipose Tissue; Animals; Body Weight; Diet; Dietary Supplements; Docosahexaenoic Acids; Eicosapentae | 2019 |
Serum n-3 polyunsaturated fatty acids are inversely associated with longitudinal changes in depressive symptoms during pregnancy.
Topics: Adult; Brazil; Depression; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Fe | 2017 |
Omega-3 fatty acids for depression in pregnancy.
Topics: Adult; Depressive Disorder; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Fema | 2003 |
Effects of highly purified eicosapentaenoic acid on vascular reactivity to angiotensin II and norepinephrine in pregnant rabbits.
Topics: Angiotensin II; Animals; Blood Pressure; Eicosapentaenoic Acid; Female; Infusions, Intravenous; Nore | 1997 |